phentermine has been researched along with Fatty Liver, Nonalcoholic in 2 studies
Phentermine: A central nervous system stimulant and sympathomimetic with actions and uses similar to those of DEXTROAMPHETAMINE. It has been used most frequently in the treatment of obesity.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Other anti-obesity medications, including lorcaserin, setmelanotide, phentermine hydrochloric, phentermine/topiramate, and naltrexone/bupropion, have been minimally investigated in NAFLD." | 5.22 | Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver Disease. ( Germanidis, GS; Giouleme, O; Goulas, A; Goulis, DG; Polyzos, SA, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Polyzos, SA | 1 |
| Goulis, DG | 1 |
| Giouleme, O | 1 |
| Germanidis, GS | 1 |
| Goulas, A | 1 |
| Dhillon, S | 1 |
2 reviews available for phentermine and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver Disease.
Topics: Anti-Obesity Agents; Humans; Liraglutide; Non-alcoholic Fatty Liver Disease; Obesity; Orlistat; Phen | 2022 |
Phentermine/Topiramate: Pediatric First Approval.
Topics: Adolescent; Adult; Anti-Obesity Agents; Child; Delayed-Action Preparations; Diabetes Mellitus, Type | 2022 |